Cargando…
Interactions of IgG1 CH2 and CH3 Domains with FcRn
Antibody fragments are emerging as promising biopharmaceuticals because of their relatively small-size and other unique properties. However, when compared to full-size antibodies, most of the current antibody fragments of VH or VL display greatly reduced half-lives. A promising approach to overcome...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980117/ https://www.ncbi.nlm.nih.gov/pubmed/24765095 http://dx.doi.org/10.3389/fimmu.2014.00146 |